Children Vaccination of COVID-19
DOI:
https://doi.org/10.51200/bjms.v15i3.3357Keywords:
COVID-19, Children VaccinationAbstract
The Delta variant is currently the highly contagious predominant variant of the SARSCoV-2 virus worldwide that causes severe illness more than the previous variants in unvaccinated people (CDC, 2021). At a White House briefing, the National Institute of Allergy and Infectious Diseases director, Anthony Fauci, predicted that there would be an increase in the number of child hospitalisation proportionate to the increased number of children getting infected with the Delta variant (Press briefing White House, 2021). In response to this situation, the FDA (U.S. Food and Drug Administration) approved Pfizer-BioNTech and Moderna vaccines for children aged 12 – 17 years. Vaccines in children aged 5 – 11 years are currently under clinical trial (Sick-Samuels & Messina, 2021).
Downloads
Published
How to Cite
Issue
Section
License
All articles are published under the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, enabling users to read, download, copy, distribute, and adapt the material for non-commercial purposes, provided proper credit is given to the original authors and the source. This model supports transparency, accessibility, and the global exchange of medical knowledge.

